BOSTON (MarketWatch) -- Drug stocks closed higher Monday, with shares of Pharmion Corp., GPC Biotech AG and Spectrum Pharmaceuticals all soaring after a clinical study showed promising results from a ...
Co announces that a three-arbitrator panel of the American Arbitration Association, which was appointed to resolve a dispute over claims raised by Spectrum Pharmaceuticals against GPC Biotech ...
As a result of these numerous, material breaches, Spectrum's Demand also seeks a declaration that GPC Biotech's breaches provide a basis for termination of the License Agreement. If the License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback